The Need for Individualized Risk Assessment in Cardiovascular Disease

Area of Science:

• Biomedical science
• Cardiovascular medicine
• Thrombosis research

Background:

• Cardiovascular disease is a leading cause of mortality globally.
• Current risk markers for cardiovascular disease are insufficient for individual prediction.
• Accurate prediction of thrombosis and bleeding is crucial for timely interventions.

Purpose of the Study:

• To explore the pathophysiology of cardiovascular disease through Virchow's triad.
• To highlight the need for improved individual risk assessment tools.
• To discuss multimodal approaches for assessing thrombosis and bleeding risks.

Main Methods:

• Review of the pathophysiology of cardiovascular disease.
• Analysis of Virchow's triad: hypercoagulability, endothelial dysfunction, and vessel flow.
• Exploration of advanced assessment tools: global coagulation assays, endothelial biomarkers, and vessel flow analysis.

Main Results:

• Virchow's triad provides a foundational understanding of thrombosis development.
• Existing clinical markers inadequately predict individual cardiovascular disease risk.
• Multimodal assessment offers a sophisticated approach to risk stratification.

Conclusions:

• Improved understanding of Virchow's triad is essential for cardiovascular disease management.
• Individualized risk assessment requires advanced tools beyond current clinical markers.
• Integrating global coagulation assays, endothelial biomarkers, and vessel flow assessment can enhance prediction of thrombosis and bleeding risks.